N-GLYCIDYL-SUBSTITUTED AMIDE COMPOUNDS

Abstract: Novel compounds represented by the formula: wherein R₁ represent an aliphatic hydrocarbyl group, an aromatic hydrocarbyl group or an alicyclic hydrocarbyl group, X represents hydrogen, a glycidoxy group or an N,N-diglycidylamino group, R₂ represents hydrogen or a methyl group, R₃ represents an alkyl group, an alkemyl group, or an aryl group, p represents 0 or 1, q represents an integer of 1 to 4; r represents 1 or 2, and s represents an integer of 1 to 4, are obtained by reacting an amide compound with a halide compound such as epihalohydrin or dihalopropanol in the presence of a strongly basic com­ pound. They are useful as starting meterials for reactive diluents, cross-linking agents, etc.

Description: DESCRIPTION N-GLYCIDYL-SUBSTITUTED AMIDE COMPOUNDS Technical Field - This invention relates to novel N-monoglycidylsubstituted, N,N-diglycidyl-substituted, or N,N,N',N',N", N"-hexaglycidyl-substituted compounds derived from aliphatic or aromatic mono- and polyamide compounds. Background Art Conventionally, the following three methods are known to be typical of the methods for the preparation of glycidyl compounds: i) Glycidyl ethers EMI1.1 ii) Glycidylamines EMI1.2 iii) Glycidyl esters EMI2.1 (M is an alkali metal ion.) EMI2.2 (R is a lower alkyl group.) On the other hand, the following two methods are known to be typical of the methods for the preparation of N-substituted amide compounds: (i) Method based on the reaction of an acid chloride with an amine EMI2.3 In order to prepare N-glycidyl-substituted amides according to this method, it is necessary to use glycidylamine of the formula EMI2.4 as a starting material. However, the use of this compound is impossible because it undergoes self-condensation and, hence, cannot exist in the free state. (ii) Method based on the Ritter reaction EMI2.5 (tertiary alcohol) Also in this method, it is impossible to use glycidyl alcohol of the formula EMI2.6 as a starting material, because it is a primary alcohol and undergoes ring cleavage under the action of an acid. Thus, the N-glycidyl-substituted amide compounds provided by the present invention have been unable to be prepared according to any conventional method. Disclosure of the Invention It is an object of the present invention to provide novel N-glycidyl-substituted amide compounds which are useful in organic chemical reactions and as raw materials for the manufacture of organic high-molecular compounds such as reactive diluents, crosslinking agents, epoxidizing agents, resin modifiers, epoxy resins, adhesives, coating materials, electronic materials, composite materials, and the like. The above object of the present invention is accomplished by providing N-glycidyl-substituted amide compounds and N- 2-methylglycidyl-substituted amide compounds as described hereinbelow. Specifically, the present invention provides Nglycidyl-substituted amide compounds having the general formula EMI3.1 where R1 is an aliphatic hydrocarbon radical, an aromatic hydrocarbon radical, or an alicyclic hydrocarbon radical; X is a hydrogen atom, a glycidoxy group, a 2-methylglycidoxy group, an N,N-diglycidylamino group, or an N,N-di-2-methylglycidylamino group. p is an integer of 0 or 1; q is an integer of 1 to 4; R2 is a hydrogen atom or a methyl group, and when R2 is a hydrogen atom, X is a hydrogen atom, a glycidoxy group, or an N,N-diglycidylamino group, while when R2 is a methyl group, X is a hydrogen atom, a 2-methylglycidoxy group, or an N,N-di-2-methylglycidylamino group; R3 is an alkyl group, an alkenyl group, or an aryl group; r is an integer of 1 or 2; and s is an integer of 1 to 4; provided that when X is a hydrogen atom, p is 0 or 1 and q is 0 or 1, in the case that s is 1, r is 1 or 2, and in the case that s is from 2 to 4, r is 2; when X is a glycidoxy group or a 2-methylglycidoxy group, p is 1 and r is 2; and when X is an N,N-diglycidylamino group or an N,N-di-2-methylglycidylamino group, p is 0 or 1, q is 1 or 2, s is 1 or 2, and r is 2. The compounds which fall within the scope of the above general formula are more specifically described hereinbelow, although the description is limited to Nglycidyl-substituted compounds for purposes of simplification. First of all, they include N-monoglycidyl-substituted or N,N-diglycidyl-substituted compounds derived from aliphatic saturated or unsaturated monoamide compounds and the Nmonoglycidyl-substituted or N,N-diglycidyl-substituted compounds derived from aromatic or alicyclic monoamide compounds. As for polyamide compounds, N,N,N',N'-tetraglycidylsubstituted compounds derived from aliphatic saturated or unsaturated diamide compounds, N,N,N',N'-tetraglycidylsubstituted compounds derived from aromatic or alicyclic diamide compounds, N,N,N1 ,N' ,N",N"-hexaglycidyl-substituted compounds derived from aromatic triamide compounds, and N,N,N',N',N",N",N"',N"'-octaglycidyl-substituted compounds derived from aromatic tetraamide compounds, and the like are included. Moreover, compounds obtained by introducing a glycidoxy group into N,N-diglycidyl-substituted compounds derived from aliphatic saturated or unsaturated monoamide compounds, compounds obtained by introducing 1 to 4 glycidoxy groups into N,N-diglycidyl-substituted compounds derived from aromatic monoamide compounds, compounds obtained by introducing 1 or 2 glycidoxy groups into N,N,N',N'tetraglycidyl-substituted compounds derived from aromatic diamide compounds, and the like are also included. Furthermore, compounds obtained by introducing 1 or 2 N,N-diglycidylamino groups into N,N-diglycidyl-substituted compounds derived from aliphatic saturated, aromatic, or alicyclic monoamide compounds, compounds obtained by introducing 1 or 2 N,N-diglycidylamino groups into N,N,N', N'-tetralycidyl-substituted compounds derived from aliphatic saturated or aromatic diamide compounds, and N,N,N',N'- tetraglycidyl-substituted compounds derived from urea are also included. Best Mode for Carrying Out the Invention In order to prepare the compounds of the present invention most efficiently, there can be employed the process for the preparation of N-substituted amide compounds which is disclosed in the previously filed Japanese Patent Application No. 4610/'81 and the like. More specifically, this process comprises reacting an amide compound with a halogen-substituted compound in an aprotic solvent in the presence of a strongly basic substance, whereby an Nsubstituted amide compound is prepared according to the following reaction formula: EMI6.1 where R is, for example, an alkyl group, R' is an alkyl group, and X is a halogen. In the above reaction formula, an epihalohydrin or dihalo-propanol, or a B-methylepihalohydrin or dihalo ss-methylpropanol may be used as the halogen-substituted compound to prepare N-substituted amides having a glycidyl or 2-methylglycidyl substituent, respectively. Moreover, a mixture of a compound as described above and a halide selected from alkyl halides, alkenyl halides, and aryl halides may be used as the halogen-substituted compound to prepare N,N-disubstituted amide compounds having a glycidyl or 2-methylglycidyl substituent and a residue corresponding to the halide. Although the yield of the desired product is reduced as compared with the above-described process, the compounds of the present invention can also be prepared by a number of alternative processes. Speicifically, they include a process in which an amide compound is reacted with a strongly basic substance in an aprotic solvent and, thereafter, a halogen-substituted compound is introduced into the reaction system to prepare an N-substituted amide compound; a process in which an amide compound is reacted with a halogen-substituted compound by the utilization of an phase transfer reaction to prepare an N-substituted amide compound; a process in which an N-substituted amide compound is prepared by using fluoride ions as a catalyst for the removal of hydrogen fluoride; and the like. As regards N-glycidyl-substituted amides, for example, the compounds of the present invention are classified into a number of categories: N-glycidyl-substituted compounds derived from monoamide compounds, N-glycidylsubstituted compounds derived from diamide and higher polyamide compounds, N-glycidyl-substituted glycidyl ether compounds derived from hydroxyl-substituted monoamide compounds, N-glycidyl-substituted glycidyl ether compounds derived from hydroxyl-substituted diamide compounds, N-glycidyl-substituted compounds derived from amino-substituted monoamide compounds, N-glycidylsubstituted compounds derived from amino-substituted diamide compounds, and the like. The N-glycidyl-substituted amide compounds derived from monoamide compounds include monoglycidylsubstituted compounds of the general formula EMI8.1 and diglycidyl-substituted compounds of the general formula EMI8.2 In the above formulas, R1 is selected from alkyl, alkenyl, aryl, and alicyclic groups. The alkyl groups are represented by the general formula CnH2n+1ffi where n is an integer of 0 to 20. The alkenyl groups are represented by the general. formula CnH2n 1- where n is an integer of 2 to 20. The aryl groups are substituent groups containing an aromatic ring and include arylalkyl and arylalkenyl groups. The aromatic ring can be a benzene, naphthalene, anthracene ring, or the like. The alicyclic groups are substituent groups having an alicyclic structure. In addition, R1 can be any of substituent groups obtained by introducing one or more atoms of at least one halogen into the hydrocarbon moiety of the foregoing substituent groups. On the other hand, R2 in the general formula (1) is selected from alkyl, alkenyl, and aryl groups. The alkyl groups are represented by the general formula CnH2n+l- where n is an integer of 1 to 20. The alkenyl groups are represented by the general formula CnH2n-1 where n is an integer of 2 to 20. The aryl groups are substituent groups containing an aromatic ring and include arylalkyl and arylalkenyl groups. The aromatic ring can be a benzene, naphthalene, anthracene ring, or the like. Among the N-glycidyl-substituted amide compounds derived from polyamide compounds, those derived from diamide compounds can be represented by the general formula EMI9.1 where R1 is selected from alkylene, alkenylene, arylene, and alicyclic groups. The alkylene groups are represented by the general formula -CnH2n- where n is an integer of 0 to 20. The alkenylene groups are represented by the general formula -CnH2n-2 where n in an integer of 2 to 20. The arylene groups are substituent groups containing an aromatic ring and include arylalkylene and arylalkenylene groups. The aromatic ring can be a benzene, naphthalene, anthracene ring, or the like. The alicyclic groups are substituent groups having an alicyclic structure. In addition, R1 can be any of substituent groups obtained by introducing one or more atoms of at least one halogen into the hydrocarbon moiety of the foregoing substituent groups. The N-glycidyl-substituted amide compounds derived from triamide compounds can be represented by the general formula EMI10.1 where R1 is an aromatic ring or an alicyclic group. The aromatic ring can be a benzene, naphthalene, anthracene ring, or the like. In addition, R1 can be an aromatic ring substituted by one or more atoms of at least one halogen. The N-glycidyl-substituted amide compounds derived from tetraamide compounds can be represented by the general formula EMI11.1 where R1 is an aromatic ring or an alicyclic group. The aromatic ring can be a benzene, naphthalene, anthracene ring, or the like. In addition, R1 can be an aromatic ring substituted by one or more atoms of at least one halogen. The N-glycidyl-substituted glycidyl ether compounds derived from hydroxyl-substituted monoamide compounds can be represented by the general formula EMI11.2 where n is an integer of 1 to 4. When n is 1, R1 is selected from alkylene, alkenylene, and arylene groups. When n is from 2 to 4, R1 is an aromatic ring which can be a benzene, naphthalene, anthracene ring, or the like. The alkylene groups are represented by the general formula C H where n is an integer of 1 to 20. The alkenylene groups are represented by the general formula -CnH2n 2- where n is an integer of 2 to 20. The arylene groups are substituent groups containing an aromatic ring which can be a benzene, naphthalene, anthracene ring, or the like. In addition, R1 can be any of substituent groups obtained by introducing one or more atoms of at least one halogen into the hydrocarbon moiety of the foregoing substituent groups. The N-glycidyl-substituted glycidyl ether compounds derived from hydroxyl-substituted diamide compounds can be represented by the general formula EMI12.1 where n is an integer of 1 or 2 and R1 is an aromatic ring which can be a benzene, naphthalene, anthracene ring, or the, like. In addition, R1 can be an aromatic ring substituted by one or more atoms of at least one halogen. The N-glycidyl-substituted amide compounds derived from amino-substituted monoamide compounds can be represented by the general formula EMI12.2 where n is an integer of 1 or 4 and R1 is selected from alkylene, arylene, and alicyclic groups. The alkylene groups are represented by the general formula -C where n 2n where n is an integer of 1 to 20. The arylene groups are substituent groups containing an aromatic ring and include arylalkyl groups. The aromatic ring can be a benzene, naphthalene, anthracene ring, or the like. The alicyclic groups are substituent groups having an alicyclic structure. In addition, R1 can be any of substituent groups obtained by introducing one or more atoms of at least one halogen into the hydrocarbon moiety of the foregoing substituent groups. The N-glycidyl-substituted amide compounds derived from amino-substituted diamide compounds can be represented by the general formula EMI13.1 where n is an integer of 1 or 2 and R1 is an aromatic ring which can be a benzene, naphthalene, anthracene ring, or the like. In addition, R1 can be an aromatic ring substituted by one or more atoms of at least one halogen. Besides, N,N,N',N'-tetraglycidylurea is included as an N-glycidyl-substituted amide compound derived from urea. Typical examples of the N-glycidyl-substituted amide compounds of the present invention are given hereinbelow. Among the N-glycidyl-substituted amide compounds derived from monoamide compounds, the N-monoglycidylsubstituted compounds include, for example, N-methyl-Nglycidylacetaminde, N-ethyl-N-glycidylformamide, N-butyl N-glycidylpropionamide, N-methyl-N-glycidylstearamide, N-decyl-N-glycidyllauramide, N-stearyl-N-glycidylpropionamide, N-allyl-N-glycidylacetamide, N-methallyl-N-glycidylpropionamide, N-butenyl-N-glycidylformamide, N-hexenyl-N-glycidylstearamide, N-benzyl-N-glycidylformamide, N-phenetyl-N-glycidylacetamide, N-phenylpropyl-N-glycidylpropionamide, N-cinnamyl-Nglycidyllauramide, N-methyl-N-glycidylacrylamide, N-methyl N-glycidylmethacrylamide, N-ethyl-N-glycidylcrotonamide, N-butyl-N-glycidylacrylamide, N-methyl-N-glycidyldecenamide, N-decyl-N-glycidylbutenamide, N-stearyl-N-glycidylcrotonamide, N-allyl-N-glycidylacrylamide, N-allyl-N-glycidylmethacrylamide, N-methallyl-N-glycidylcrotonamide, N-butenyl-N-glycidylmethacrylamide, N-hexyl-N-glycidyldecenamide, N-benzyl-Nglycidylacrylamide, N-phenetyl-N-glycidylacrylamide, Nphenetyl-N-glycidylcrotonamide, N-phenylpropyl-N-glycidylmethacrylamide, N-cinnamyl -N-glycidyldecenamide, N-methyl N-glycidylbenzamide, N-ethyl-N-glycidyltolylamide, N-butyl N-glycidylphenylacetamide, N-methyl-N-glycidylcinnamamide, N-decyl-N-glycidylnaphthalenecarboxamide, N-stearyl-Nglycidylanthracenecarboxamide, N-allyl-N-glycidylbenzamide, N-methallyl-N-glycidyltolylamide, N-butenyl-N-glycidylphenylacetamide, N-hexenyl-N-glycidylallylbenzamide, Nbenzyl-N-glycidylbenzamide, N-phenetyl-N-glycidyltolylamide, N-benzyl-N-glycidylcinnamamide, N-phenySpropyl-N-glycidyl- phenylacetamide, N-methyl-N-glycidylcyclohexanecarboxamide, N-ethyl-N-glycidylcyclohexylacetamide, N-butyl-N-glycidylcyclohexanecarboxamide, N-decyl-N-glycidylcyclohexylpropionamide, N-allyl-N-glycidylcyclohexanecarboxamide, N-methallyl-N-glycidylcyclohexylacetamide, N-benzyl-Nglycidylcyclohexanecarboxamide, N-phenetyl-N-glycidylcyclohexylacetamide, and the like. The N,N-diglycidyl-substituted compounds include, for example, N,N-diglycidylformamide, N,N-diglycidylacetamide, N,N-diglycidylpropionamide, N,N-diglycidylbutyramide, N,N-diglycidylchloroacetamide, N,N-diglycidylchloropropionamide, N,N-diglycidyldichloroamide, N,Ndiglycidylacrylamide, N,N-diglycidylmethacrylamide, N,Ndiglycidylcrotonamide, N,N-diglycidylvinylacetamide, N,Ndiglycidyldecenamide, N,N-diglycidylnonadecenamide, N,Ndiglycidylchloroacrylamide, N,N-diglycidylbenzamide, N,N-diglycidylnaphthalenecarboxamide, N,N-diglycidylanthracenecarboxamide, N,N-diglycidyltolylamide, N,Ndiglycidylphenylacetamide, N,N-diglycidylphenylpropionamide, N,N-diglycidylphenyldecanamide, N,N-diglycidylphenylacrylamide, N,N-diglycidylbenzylacrylamide, N,N-diglycidylcinnamamide, N,N-diglycidylallylbenzamide, N,N-diglycidylchlorobenzamide, N,N-diglycidyldichlorobenzamide, N,Ndiglycidylchlorobromobenzamide, N,N-diglycidylcyclobutanecarboxamide, N,N-diglycidylcyclopentanecarboxamide, N,Ndiglycidylcyclohexanecarboxamide, N,N-diglycdyl- cyclopentanecarboxamide, N,N-diglycidylcyclohexylacetamide, N,N-diglycidylcyclohexylpropionamide, N,N-diglycidylcyclohexenecarboxamide, N,N-diglycidylcyclohexadienecarboxamide, N,N-diglycidylcyclopentylphenylacetamide, and the like. The N-glycidyl-substituted amide compounds derived from polyamide compounds include, for example, N,N,N',N'-tetraglycidyloxamide, N,N,N',N'-tetraglycidylmalonamide, N,N,N',N'-tetraglycidylsuccinamide, N,N,N',N'tetraglycidylglutaramide, N,N,N' ,N' -tetraglycidyladipamide, N,N,N',N'-tetraglycidylpiperamide, N,N,N',N'-tetraglycidyl- suberamide, N,N,N',N'-tetraglycidylazelamide, N,N,N',N'- tetraglycidylsebacamide, N,N,N",N'-tetraglycidyloctadecanedi- carboxamide, N,N,N',N'-tetraglycidylfumaramide, N,N,N',N'tetraglycidylmaleamide, N,N,N',N'-tetraglycidylcitraconamide, N,N,N',N'-tetraglycidylmeasaconamide, N,N,N',N'-tetraglycidyldecenedicarboxamide, N,N,N',N'-tetraglycidyloctadecenedicarboxamide, N,N,N',N'-tetraglycidylphthalamide, N,N,N',N'-tetraglycidylisophthalamide, N,N,N',N'-tetraglycidylterephthalamide, N,N,N',N' tetraglycidylnaphthalene- dicarboxamide, N,N,N',N'-tetraglycidylanthracenedicarboxamide, N,N,N',N'-tetraglycidylcarbamoylphenylacetamide, N,N,N',N'tetraglycidylphenylcitraconamide, N,N,N',N'-tetraglycidyldiphenamide, N,N,N' ,N' -tetraglycidylchloroisophthalamide, N,N,N',N'-tetraglycidylbromoisophthalamide, N,N,N',N'tetraglycidylcyclobutanedicarboxamide, N,N,N',N'-tetraglycidylcyclopentanedicarboxamide, N,N,N' ,N' -tetraglycidyl- cyclohexanedicarboxamide, N,N,N,N'-tetraglycidylcycloheptanedicarboxamide, N,N,N',N'-tetraglycidylcyclohexenedicarboxamide, N,N,N',N'-tetraglycidylcamphoramide, N,N,N',N',N",N"hexaglycidylbenzenetricarboxamide, N,N,N',N',N",N"hexaglycidylnaphthalenetricarboxamide, N,N,N',N',N",N" hexaglycidyltoluenetricarboxamide, N,N,N' ,N' ,N",N"-hexa- glycidylchlorobenzenetricarboxamide, N,N,N',N',N",N"hexaglycidylcyclohexanetricarboxamide, N,N,N' ,N',N",N",N",, N"'-octalycidylpyromellitamide, N,N,N',N',N",N",N"',N"'octaglycidylnaphthalenetetracarboxamide, N,N,NM',N',N",N", N"' ,N"' -octaglycidylcycloheptanetetracarboxamide, and the like. On the other hand, the N-glycidyl-substituted glycidyl ether compounds derived from hydroxyl-substituted monoamide compounds include, for example, N,N-diglycidylglycidoxypropionamide, N,N-diglycidylglycidoxydiphenylacetamide, N,N-diglycidylglycidoxybutyramide, N,Ndiglycidylglycidoxyheptanamide, N,N-diglycidylglycidoxydecanamide, N,N-diglycidylglycXidoxycrotonamide, N,Ndiglycidylglycidoxydimethylheptynamide, N,N-diglycidylglycidoxybenzamide, N,N-diglycidylglycidoxytolylamide, N,N-diglycidylglycidoxyphenylbenzamide, N,N-diglycidylglycidoxynaphthalenecarboxamide, N,N-diglycidyldiglycidoxybenzamide, N,N-diglycidyltriglycidoxybenzamide, N,Ndiglycidyldiglycidoxytolylamide, and the like. The N-glycidyl-substituted glycidyl ether compounds derived from hydroxyl-substituted diamide compounds include N,N,N' ,N' -tetraglycidylglycidoxyphthalamide, N,N,N',N'-tetraglycidylglycidoxyisophthalamide, N,N,N',N'tetraglycidylglycidoxyterephthalamide, N,N,N' ,N'- tetraglycidyldiglycidoxyphthalamide, N,N,N',N'-tetra glycidyldiglycidoxyisophthalamide, N,N,N',N'-tetraglycidyldiglycidoxyterephthalamide, and the like. The N-glycidyl-substituted compounds derived from amino-substituted monoamide compounds include N,N,N',N'tetraglycidylglycinamide, N,N,N' ,N' -tetraglycidylalaninamide, N,N-diglycidylamino-N,N-diglycidylbutanamide, N,N,N',N'tetraglycidyldiamino-N",N"-diglycidylpropionamide, N,N diglycidylamino-N' ,N'-diglycidylbenzamide, N,N-diglycidyl amino-N' ,N' -diglycidylchlorobenzamide, N,N-diglycidylamino N',N'-diglycidyltribromobenzamide, N,N,N' ,N'-tetraglycidyldi- amino-N",N"-diglycidylbenzamide, N,N-diglycidylaminophenyl N',N'-diglycidylacetamide, N,N-diglycidylaminophenyl-N',N'diglycidylpropionamide, N,N-diglycidylamino-N' ,N' - diglycidylnaphthalenecarboxamide, N,N-diglycidylamino-N',N'diglycidylcyclohexanecarboxamide, and the like. The N-glycidyl-substituted compounds derived from amino-substituted diamide compounds include N,N,N',N',N",N"hexaglycidylaspartdiamide, N,N-diglycidylamino-N',N',N",N"- tetraglycidylglutardiamide, N,N-diglycidylamino-N' ,N' ,N",N"- tetraglycidylphthalamide, N,N-diglycidylamino-N',N',N",N"tetraglycidylphthalamide, N,N-diglycidylamino-N',N',N",N"tetraglycidylterephthalamide, and the like. In addition, the N-glycidyl-substitued derivatives of urea are also included, and examples thereof are N,N,N',N'tetraglycidylurea and the like. Next, typical examples of the N-2-methylglycidylsubstituted compounds of the present invention are given hereinbelow. Among the N-2-methylglycidyl-substituted amide compounds derived from monoamide compounds, the N-mono-2methylglycidyl-substituted compounds include, for example, N-methyl-N-2-methylglycidylacetamide, N-ethyl-N-2-methylglycidylformamide, N-butyl-N-2-methylglycidylpropionamide, N-methyl-N-2-methylglycidylstearamide, N-decyl-N-2methylglycidyllauramide, N-stearyl-N-2-methylglycidylpropionamide, N-allyl-N-2-methylglycidylacetamide, Nmethallyl-N-2-methylglycidylpropionamide, N-butenyl-N-2methylglycidylformamide, N-hexenyl-N-2-methylglycidylstearamide, N-benzyl-N-2-methylglycidylformamide, N-phenetyl N-2-methylglycidylacetamide, N-phenylpropyl-N-2-methylglycidylpropionamide, N-cinnamyl-N-2-methylglycidyllauramide, N-methyl-N-2-methylglycidylacrylamide, N-methyl-N-2methylglycidylmethacrylamide, N-ethyl-N-2-methylglycidylcrotonamide, N-butyl-N-2-methylglycidylacrylamide, Nmethyl-N-2-methylglycidyldecenamide, N-decyl-N-2-methylglycidylbutenamide, N-stearyl-N-2-methylglycidylcrotonamide, N-allyl-N-2-methylglycidylacrylamide, N-allyl-N-2-methylglycidylmethacrylamide, N-methallyl-N-2-methylglycidylcrotonamide, N-butenyl -N- 2 -methylglycidylmethacrylamide, N-hexenyl-N-2-methylglycidyldecenamide, N-benzyl-N-2methylglycidylacrylamide, N-phenetyl-N-2-methylglycidylacrylamide, N-phenetyl -N- 2 -methylglycidylcrotonamide, N-phenylpropyl-N-2-methylglycidylmethacrylamide, N-cinnamyl N-2-methylglycidyldecenamide, N-methyl-N-2-methylglycidylbenzamide, N-ethyl-N-2-methylglycidyltolylamide, N-butyl N-2-methylglycidylphenylacetamide, N-methyl-N-2-methylglycidylcinnamamide, N-decyl-N-2-methylglycidylnaphthalenecarboxamide, N-stearyl-N-2-methylglycidylanthracenecarboxamide, N-allyl-N-2-methylglycidylbenzamide, Nmethallyl-N-2-methylglycidyltolylamide, N-butenyl-N-2methylglycidylphenylacetamide, N-hexenyl-N-2-methylglycidylallylbenzamide, N-benzyl-N-2-methylglycidylbenzamide, Nphenetyl-N-2-methylglycidyltolylamide, N-benzyl-N-2methylglycidylcinnamamide, N-phenylpropyl-N-2-methylglycidylphenylacetamide, N-methyl-N-2-methylglycidylcyclohexanecarboxamide, N-ethyl-N-2-methylglycidylcyclohexylacetamide, N-butyl -N-2-methylglycidylcyclohexanecarboxamide, N-decyl N-2-methylglycidylcyclohexylpropionamide, N-allyl-N-2methylglycidylcyclohexanecarboxamide, N-methallyl-N-2methylglycidylcyclohexylacetamide, N-benzyl-N-2-methylglycidylcyclohexanecarboxamide, N-phenetyl-N-2-methylglycidyl- cyclohexylacetamide, and the like. The N,N-di-2-methylglycidyl-substituted compounds include, for example, N,N-di-2-methylglycidylformamide, N,N-di-2-methylglycidylacetamide, N,N-di-2-methylglycidylpropionamide, N,N-di-2-methylglycidylbutyramide, N,N-di2-methylglycidylchloroacetamide, N,N-di-2-methylglycidylchloropropionamide, N,N-di-2-methylglycidyldichloroamide, N,N-di-2-methylglycidylacrylamide, N,N-di-2-methylglycidylmethacrylamide, N,N-di-2-methylglycidylcrotonamide, N,N-di-2-methylglycidylvinylacetamide, N,N-di-2-methyl- glycidyldecenamide, N,N-di-2-methylglycidylnonadecenamide, N,N-di-2-methylglycidylchloroacrylamide, N,N-di-2methylglycidylbenzamide, N,N-di-2-methylglycidylnaphthalene carboxamide, N,N-di-2-methylglycidylanthracenecarboxamide, N,N-di-2-methylglycidyltolylamide, N,N-di-2-methylglycidylphenylacetamide, N,N-di-2-methylglycidylphenylpropionamide, N,N-di-2-methylglycidylphenyldecanamide, N,N-di-2-methylglycidylphenylacrylamide, N,N-di-2-methylglycidylbenzylacrylamide, N,N-di-2-methylglycidylcinnamamide, N,N-di-2methylglycidylallylbenzamide, N,N-di-2-methylglycidylchlorobenzamide, N,N-di-2-methylglycidyldichlorobenzamide, N,N-di-2-methylglycidylchlorobromobenzamide, N,N-di-2methylglycidylcyclobutanecarboxamide, N,N-di-2-methylglycidylcyclopentanecarboxamide, N,N-di-2-methylglycidylcyclohexanecarboxamide, N,N-di-2-methylglycidylcyclopentanecarboxamide, N,N-di-2-methylglycidylcyclohexylacetamide, N,N-di-2methylglycidylcyclohexylpropionamide, N,N-di-2-methylglycidylcyclohexenecarboxamide, N,N-di-2-methylglycidylcyclohexadienecarboxamide, N,N-di-2-methylglycidylcyclopentylphenylacetamide, and the like. The N-2-methylglycidyl-substituted amide compounds derived from polyamide compounds include, for example, N,N,N',N'-tetra-2-methyl- glycidyloxamide, N,N,N' ,N' -tetra-2-methylglycidylmalonamide, N,N,N',N'-tetra-2-methylglycidylsuccinamide, N,N,N',N'tetra-2-methylglycidylglutaramide, N,N,N',N'-tetra-2 methylglycidyladipamide, N,N,N' ,N'-tetra-2-methylglycidyl- pimelamide, N,N,N',N'-tetera-2-methylglycidylsuberamide, N,N,N',N'-tetra-2-methylglycidylazelamide, N,N,N',N'tetra-2-methylglycidylsebacamide, N,N,N',N'-tetra-2methylglycidyloctadecanedicarboxamide, N,N,N' ,N1-tetra-2- methylglycidylfumaramide, N,N,N',N'-tetra-2-methylglycidylmaleamide, N,N,N',N'-tetra-2-methylglycidylcitraconamide, N,N,N',N'-tetra-2-methylglycidylmesaconamide, N,N,N',N'tetra-2-methylglycidyldecenedicarboxamide, N,N,N' ,N' - tetra-2-methylglycidyloctadecenedicarboxamide, N,N,N' ,N' - tetra-2-methylglycidylphthalamide, N,N,N' ,N'-tetra-2- methylglycidylisophthalamide, N,N,N' ,N'-tetra-2-methyl- glycidylterephthalamide, N,N,N' ,N'-tetra-2-methylglycidyl- naphthalenedicarboxamide,N,N,N',N'-tetra-2-methylglycidylanthracenedicarboxamide,N,N,N',N'-tetra-2-methylglycidylcarbamoylphenylacetamide,N,N,N',N'-tetra-2-methylglycidylphenylcitraconamide, N,N,N',N'-tetra-2-methylglycidyl- diphenamide, N,N,N' ,N'-tetra-2-methylglycidylchloroisophtha- lamide, N,N,N',N'-tetra-2-methylglycidylbromoisophthalamide, N,N,N',N'-tetra-2-methylglycidylcyclobutanedicarboxamide, N,N,N',N'-tetra-2-methylglycidylcyclopentanedicarboxamide, N,N,N',N'-tetra-2-methylglycidylcyclohexanedicarboxamide, N,N,N',N'-tetra-2-methylglycidylcycloheptanedicarboxamide, N,N,N',N'-tetra-2-methylglycidylcyclohexenedicarboxamide, N,N,N' ,N'-tetra-2-methylglycidylcamphoramide, N,N,N',N',N", N"-hexa-2-methylglycidylbenzenetricarboxamide, N,N,N',N',N", N"-hexa-2-methylglycidylnaphthalenetricarboxamide, N,N,N' ,N' ,N",N"-hexa-2-methylglycidyltoluenetricarboxamide, N,N,N' ,N' ,N" ,N"-hexa-2-methylglycidylchlorobenzene- tricarboxamide, N,N,N' ,N' ,N",N"-hexa-2-methylglycidyl- cyclohexanetricarboxamide, <RTI ID=23.3> N,N,N',N',N",N",N"',N"'-octa- 2-methylglycidylpyromellitamide, N,N,N',N',N",N",N"',N"' octa-2-methylglycidylnaphthalenetetracarboxamide, N,N,N' ,N', N",N" ,N"' ,N"' -octa- 2-methylglycidylcycloheptanetetra carboxamide, and the like. On the other hand, the N-2-methylglycidylsubstituted 2-methylglycidyl ether compounds derived from hydroxyl-substituted monoamide compounds include, for example, N,N-di-2-methylglycidyl-2-methylglycidoxypropionamide, N,N-di-2-methylglycidyl-2-methylglycidoxydiphenylacetamide, N,N-di-2-methylglycidyl-2-methylglycidoxybutyramide, N,N di-2-methylglycidyl-2-methylglycidoxyheptanamide, N,N-di2-methylglycidyl-2-methylglycidoxydecanamide, N,N-di-2methylglycidyl-2-methylglycidoxycrotonamide, N,N-di-2 methylglycidyl-2-methylglycidoxydimethylheptynamide, N,Ndi-2-methylglycidyl-2-methylglycidoxybenzamide, N,N-di-2methylglycidyl-2-methylglycidoxytolylamide, N,N-di-2methylglycidyl-2-methylglycidoxyphenylbenzamide, N,N-di 2-methylglycidyl -2-methylglycidoxynaphthalenecarboxamide, N,N-di-2-methylglycidyl-di-2-methylglycidoxybenzamide, N,N-di-2-methylglycidyl-tri-2-methylglycidoxybenzamide, N,N-di-2-methylglycidyl-di-2-methylglycidoxytolylamide, and the like. The N-2-methylglycidyl-substituted 2-methylglycidyl ether compounds derived from hydroxyl-substituted diamide compounds include N,N,N',N'-tetra-2-methylglycidyl-2- methylglycidoxyphthalamide, N,N,N' ,N' -tetra-2-methyl- glycidyl-2-methylglycidoxyisophthalamide, N,N,N',N'-tetra 2-methylglycidyl-2-methylglycidoxyterephthalamide, N,N,N' ,N' - tetra-2-methylglycidyl-di-2-methylglycidoxyphthalamide, N,N,N',N'-tetra-2-methylglycidyl-di-2-methylglycidoxyisophthalamide, N,N,N',N'-tetra-2-methylglycidyl-di-2methylglycidoxyterephthalamide, and the like. The N- 2-methylglycidyl-substituted compounds derived from amino-substituted monoamide compounds include N,N,N',N'-tetra-2-methylglycidylglycinamide,N,N,N',N'tetra-2-methylglycidylalaninamide, N,N-di-2-methylglycidyl amino-N' ,N'-di-2-methylglycidylbutanamide, N,N,N',N'- tetra-2-methylglycidyldiamino-N",N"-di-2-methylglycidylpropionamide, N,N-di-2-methylglycidylamino-N',N'-di-2methylglycidylbenzamide, N,N-di-2-methylglycidylamino N1 ,N1-di-2-methylglycidylchlorobenzamide, N,N-di-2 methylglycidylamino-N' ,N' -di-2-methylglycidyltribromo- benzamide, N,N,N',N'-tetra-2-methylglycidyldiamino-N",N"di-2-methylglycidylbenzamide, N,N-di-2-methylglycidyl aminophenyl-N' ,N'-di-2-methylglycidylacetamide, N,N-di2-methylglycidylaminophenyl-N',N'-di-2-methylglycidylpropionamide, N,N-di-2-methylglycidylamino-N',N'-di-2methylglycidylnaphthalenecarboxamide, N,N-di-2-methylglycidyl amino-N' ,N' -di-2-methylglycidylcyclohexanecarboxamide, and the like. The N-glycidyl-substituted compounds derived from amino-substituted diamide compounds include N,N,N' ,N' ,N", N"-hexa- 2-methylglycidylaspartdiamide, N,N-di-2-methyl - glycidylamino-N',N',N",N"-tetra-2-methylglycidylglutardiamide, N,N-di-2-methylglycidylamino-N',N',N1,,N"-tetra-2- methylglycidylphthalamide, N,N-di-2-methylglycidylamino N',N',N",N"-tetra-2-methylglycidylisophthalamide, N,N-di 2-methylglycidylamino-N' ,N' ,N",N"-tetra-2-methylglycidyl- terephthalamide, and the like. In addition, the N-2-methylglycidyl-substituted derivatives of urea are also included, and specific examples thereof are N,N,N',N'-tetra-2-methylglycidylurea and the like. Among the above-enumerated compounds, N-glycidylor N-2-methylglycidyl-substituted compounds derived from lower fatty acid amides can be isolated and purified with comparative ease by such procedures as distillation and the like. However, other N-glycidyl- or N-2-methylglycidylsubstituted compounds, particularly N,N-diglycidyl or N,Ndi-2-methylglycidyl compounds, are so low in volatility that it is difficult to isolate them by such procedures as distillation and the like. On the other hand, glycidyl and 2-methylglycidyl groups constitute highly reactive substituents and, therefore, react with reactive compounds such as alkaline substances coexisting in the reaction system to cause side reactions such as cleavage of the epoxy ring, the ensuing addition condensation, and the like. Accordingly, the epoxy equivalent of the product tends to become higher than the theoretical value and the magnitude of the deviation depends on the reactivity of the amide compound used. Generally, aromatic amide compounds seem to give an epoxy equivalent approaching the theoretical value. The above-described N-glycidyl-substituted amide compounds and N- 2-methylglycidyl-substituted amide compounds of the present invention have wide applications in the manufacture of reactive diluents, crosslinking agents, epoxidizing agents, resin modifiers, epoxy resins, adhesives, coating materials, electronic materials, composite materials, and the like, as is the case with conventionally known monoglycidyl ether compounds such as butyl glycidyl ether, allyl glycidyl ether, and phenyl glycidyl ether; monoglycidyl ester compounds such as glycidyl methacrylate; diglycidyl ether compounds typified by bisphenol epoxy resins; diglycidyl ester compounds such as diglycidyl phthalate; diglycidylamine compounds such as N,N-diglycidylaniline and N,N-diglycidyltoluidine; tetraglycidylamine compounds such as N,N,N',N'-tetraglycidylxylylenediamine and N,N,N' ,N' -tetraglycidyldiaminodiphenylmethane; mono-2methylglycidyl ether compounds such as phenyl 2-methylglycidyl ether; mono-2-methylglycidyl ester compounds such as 2methylglycidyl methacrylate; di-2-methylglycidyl ether compounds typified by methyl-substituted bisphenol epoxy resins; di-2-methylglycidyl ester compounds such as di-2methylglycidyl terephthalate; di-2-methylglycidylamine compounds; tetra-2-methylglycidylamine compounds; and the like. The present invention is further illustrated by the following examples. Example 1 (Preparation of N,N-diglycidylpropionamide) To 150 ml of dimethyl sulfoxide (hereinafter abbreviated as DMSO) were added 15 g of propionamide, 56 g of epichlorohydrin, and 20 g of sodium hydroxide. The resulting mixture was allowed to react at 400for 4 hours. After completion of the reaction, the reaction mixture was filtered to remove any insoluble matter, and 200 ml of benzene and 150 ml of distilled water were added thereto. After vigorous stirring, the resulting mixture was separated in a separatory funnel and the aqueous layer was further extracted twice with 100-ml portions of benzene. The combined benzene layers were dried over magnesium sulfate and then distilled under reduced pressure. A fraction boiling at 114-1160C (3 mmHg) was collected to obtain 27 g of N,N-diglycidylpropionamide in a 73% yield. Titration with perchlorate revealed that its epoxy equivalent was 94 g/eq. (theoretical value, 93 g/eq.). Examples 2 to 4 Using the combinations of starting materials, strongly basic substance and solvent shown in Table 1, reaction was carried out under the conditions shown in Table 1. In these examples, 0.05 g of phenothiazine was added to the reaction mixture. After completion of the reaction, the reaction mixture was worked up in entirely the same manner as in Example 1 to obtain the results shown in Table 2. Table 1 EMI29.1 <SEP> Amide <SEP> Halogen- <SEP> Strongly <SEP> Reaction <SEP> tem Example <SEP> compound <SEP> substituted <SEP> basic <SEP> sub- <SEP> Solvent <SEP> perature <SEP> ( C)/ <tb> <SEP> (g) <SEP> compound <SEP> (g) <SEP> stance <SEP> (g) <SEP> (ml) <SEP> time <SEP> (h) <tb> <SEP> 2 <SEP> Acrylamide, <SEP> Epichloro- <SEP> Sodium <SEP> hy- <SEP> DMSO, <SEP> 40/4 <tb> <SEP> 14 <SEP> hydrin, <SEP> 56 <SEP> droxide, <SEP> 20 <SEP> 150 <tb> <SEP> 3 <SEP> Methacryl- <SEP> Epichloro- <SEP> Sodium <SEP> hy- <SEP> DMSO, <SEP> 40/4 <tb> <SEP> amide, <SEP> 17 <SEP> hydrin, <SEP> 56 <SEP> droxide, <SEP> 20 <SEP> 150 <tb> <SEP> 4 <SEP> Crotonam- <SEP> Epichloro- <SEP> Potassium <SEP> hy- <SEP> DMF, <SEP> 40/3 <tb> <SEP> ide, <SEP> 17 <SEP> hydrin, <SEP> 56 <SEP> droxide, <SEP> 28 <SEP> 150 <tb> DMF: N,N-Dimethylformamide. Table 2 EMI29.2 Example <SEP> Product <SEP> Distillation <SEP> conditions <SEP> Yield <SEP> (g) <SEP> Epoxy <SEP> equivalent <tb> <SEP> [temperature <SEP> ( C)/ <SEP> (percentage) <SEP> (g/eq.) <SEP> (theoretical <tb> <SEP> pressure <SEP> (mmHg)] <SEP> value) <tb> 2 <SEP> N,N-Diglycidyl- <SEP> 118-120/3 <SEP> 26(72) <SEP> 93(92) <tb> <SEP> acrylamide <tb> 3 <SEP> N,N-Diglycidyl- <SEP> 116-118/3 <SEP> 30(76) <SEP> 100(99) <tb> <SEP> methacrylamide <tb> 4 <SEP> N,N-Diglycidyl- <SEP> 128-131/3 <SEP> 20(51) <SEP> 101(99) <tb> Example 5 (Preparation of N-n-butyl-N-glycidylacrylamide) To 150 ml of DMSO were added 14 g of acrylamide, 37 g of epichlorohydrin, 46 g of n-butyl chloride, 20 g of sodium hydroxide, and 0.05 g of phenothiazine. The resulting mixture was allowed to react at 400C for 5 hours. After completion of the reaction, the reaction mixture was filtered to remove any insoluble matter, and then stripped of the starting materials and the solvent. To the residue were added 100 ml of benzene and 50 ml of distilled water. After vigorous stirring, the resulting mixture was separated in a separatory funnel and the aqueous layer was further extracted twice with 50-ml portions of benzene. The combined benzene layers were dried over magnesium sulfate and then distilled under reduced pressure. A fraction boiling at 103-1050C (5 mmHg) was collected to obtain 22 g of N-n-butyl-N-glycidylacrylamide in a 59% yield. Titration with perchlorate revealed that its epoxy equivalent was 184 g/eq. (theoretical value, 183 g/eq.). Examples 6 to 10 Using the combinations of starting materials, strongly basic substance and solvent shown in Table 3, reaction was carried out under the conditions shown in Table 3. After completion of the reaction, the reaction mixture was worked up in entirely the same manner as in Example 5 to obtain the results shown in Table 4. Table 3 EMI31.1 Example <SEP> Amide <SEP> Halogen- <SEP> Strongly <SEP> Solvent <SEP> Reaction <SEP> tem <SEP> compound <SEP> substituted <SEP> basic <SEP> sub- <SEP> (ml) <SEP> perature <SEP> ( C)/ <tb> <SEP> (g) <SEP> compound <SEP> (g) <SEP> stance <SEP> (g) <SEP> time <SEP> (h) <tb> 6 <SEP> Acrylamide, <SEP> Allyl <SEP> chlo- <SEP> Sodium <SEP> hy- <SEP> DMSO, <SEP> 40/4 <tb> <SEP> 14 <SEP> ride, <SEP> 23 <SEP> droxide, <SEP> 20 <SEP> 150 <tb> <SEP> Epichloro <SEP> hydrin, <SEP> 37 <tb> 7 <SEP> Acrylamide, <SEP> Benzyl <SEP> chlo- <SEP> Sodium <SEP> hy- <SEP> DMF, <SEP> 40/5 <tb> <SEP> 14 <SEP> ride, <SEP> 38 <SEP> droxide, <SEP> 20 <SEP> 150 <tb> <SEP> Epichloro <SEP> hydrin, <SEP> 37 <tb> 8 <SEP> Methacryl, <SEP> Allyl <SEP> chlo- <SEP> Sodium <SEP> hy- <SEP> DMSO, <SEP> 40/5 <tb> <SEP> amide, <SEP> 14 <SEP> ride, <SEP> 23 <SEP> droxide, <SEP> 20 <SEP> 150 <tb> <SEP> Epichloro <SEP> hydrin, <SEP> 37 <tb> 9 <SEP> Acetamide, <SEP> Allyl <SEP> chlo- <SEP> Sodium <SEP> hy- <SEP> DMSO, <SEP> 40/5 <tb> <SEP> 12 <SEP> ride, <SEP> 23 <SEP> droxide, <SEP> 20 <SEP> 150 <tb> <SEP> Epichloro <SEP> hydrin, <SEP> 37 <tb> 10 <SEP> Benzamide, <SEP> Metyl <SEP> chlo- <SEP> Potassium <SEP> hy- <SEP> DMF, <SEP> 40/5 <tb> <SEP> 24 <SEP> ride, <SEP> 15 <SEP> droxide, <SEP> 28 <SEP> 150 <tb> <SEP> Epichloro <SEP> hydrin, <SEP> 37 <tb> Table 4 EMI32.1 Example <SEP> Product <SEP> Distillation <SEP> con- <SEP> Yield <SEP> (g) <SEP> Epoxy <SEP> equiv <SEP> ditions <SEP> [tempera- <SEP> (percentage) <SEP> alent <SEP> (g/eq.) <tb> <SEP> ture <SEP> ( C)/pressure <SEP> (theoretical <tb> <SEP> (mmHg)] <SEP> value) <tb> 6 <SEP> N-Allyl-N-gly <SEP> 74-76/2 <SEP> 21(62) <SEP> 168(167) <tb> <SEP> cidylacrylamide <tb> 7 <SEP> N-Benzyl-N-gly- <SEP> 137-139/2 <SEP> 22(51) <SEP> 218(217) <tb> <SEP> cidylacrylamide <tb> 8 <SEP> N-Allyl-N-gly- <SEP> 82-84/3 <SEP> 23(63) <SEP> 181(181) <tb> <SEP> cidylmethacryl <SEP> amide <tb> 9 <SEP> N-Allyl-N-gly- <SEP> 76-78/3 <SEP> 22(70) <SEP> 155(155) <tb> <SEP> cidylacetamide <tb> 10 <SEP> N-Methyl-N-gly- <SEP> 106-108/0.5 <SEP> 20(53) <SEP> 193(191) <tb> <SEP> cidylacetamide <tb> Example 11 (Preparation of N,N-diglycidylbenzamide) To 150 ml of DMSO were added 24 g of benzamide, 56 g of epichlorohydrin, and 20 g of sodium hydroxide. The resulting mixture was allowed to react at 400C for 2 hours. After completion of the reaction, the reaction mixture was filtered to remove any insoluble matter, and then stripped of the starting materials and the solvent. To the residue were added 100 ml of benzene and 50 ml of distilled water. After vigorous stirring, the resulting mixture was separated in a separatory funnel and the aqueous layer was further extracted twice with 50-ml portions of benzene. The combined benzene layers were dried over magnesium sulfate. After benzene was distilled off, the remaining solvent and the like were removed by distillation at 1200C and 2 mmHg to obtain 42 g of N,N-diglycidylbenzamide in a 91% yield. Titration with perchlorate revealed that its epoxy equivalent was 119 g/eq. (theoretical value, 117 g/eq.). Moreover, its refractive index at 250C was found to be 1.5410. Examples 12 to 25 Using the combinations of starting materials, strongly basic substance and solvent shown in Table 5, reaction was carried out under the conditions shown in Table 5. After completion of the reaction, the reaction mixture was worked up in entirely the same manner as in Example 11 to obtain the results shown in Table 6. Table 5 EMI34.1 Example <SEP> Amide <SEP> Halogen- <SEP> Strongly <SEP> Solvent <SEP> Reaction <SEP> tem <SEP> compound <SEP> substituted <SEP> basic <SEP> sub- <SEP> (ml) <SEP> perature <SEP> ( C)/ <tb> <SEP> (g) <SEP> compound <SEP> (g) <SEP> stance <SEP> (g) <SEP> time <SEP> (h) <tb> 12 <SEP> Phenylacet <SEP> Epichloro- <SEP> Sodium <SEP> hy- <SEP> DMF, <SEP> 40/5 <tb> <SEP> amide, <SEP> 27 <SEP> hydrin, <SEP> 56 <SEP> droxide, <SEP> 20 <SEP> 150 <tb> 13 <SEP> p-Tolyam- <SEP> Epichloro- <SEP> Sodium <SEP> hy- <SEP> NMP, <SEP> 40/5 <tb> <SEP> ide, <SEP> 27 <SEP> hydrin, <SEP> 56 <SEP> droxide, <SEP> 20 <SEP> 150 <tb> 14 <SEP> Isophthal- <SEP> Epichloro- <SEP> Sodium <SEP> hy- <SEP> DMSO, <SEP> 40/4 <tb> <SEP> amide, <SEP> 27 <SEP> hydrin, <SEP> 83 <SEP> droxide, <SEP> 28 <SEP> 150 <tb> 15 <SEP> Terephthal- <SEP> Epichloro- <SEP> Potassium <SEP> hy- <SEP> DMSO, <SEP> 50/4 <tb> <SEP> amide, <SEP> 25 <SEP> hydrin, <SEP> 83 <SEP> droxide, <SEP> 39 <SEP> 150 <tb> 16 <SEP> Phthalam- <SEP> Epichloro- <SEP> Potasium <SEP> hy- <SEP> DMSO, <SEP> 50/4 <tb> <SEP> amide, <SEP> 27 <SEP> hydrin, <SEP> 83 <SEP> droxide, <SEP> 39 <SEP> 150 <tb> 17 <SEP> p-Hydroxy- <SEP> Epichloro- <SEP> Sodium <SEP> hy- <SEP> DMSO, <SEP> 40/4 <tb> <SEP> benzamide, <SEP> hydrin, <SEP> 74 <SEP> droxide, <SEP> 28 <SEP> 150 <tb> <SEP> 27 <tb> Table 5 (Cont'd) EMI35.1 Amide <SEP> Halogen- <SEP> Strongly <SEP> Reaction <SEP> tem Example <SEP> compound <SEP> substituted <SEP> basic <SEP> sub- <SEP> Solvent <SEP> perature <SEP> ( C)/ <tb> <SEP> (g) <SEP> compound <SEP> (g) <SEP> stance <SEP> (g) <SEP> (ml) <SEP> time <SEP> (h) <tb> <SEP> 20 <SEP> Monochloro- <SEP> Epichloro- <SEP> Sodium <SEP> hy- <SEP> NMP, <SEP> 40/4 <tb> <SEP> acetamide, <SEP> hydrin <SEP> 56 <SEP> droxide, <SEP> 20 <SEP> 150 <tb> <SEP> 19 <tb> <SEP> 21 <SEP> Lactamide, <SEP> Epichloro- <SEP> Sodium <SEP> hy- <SEP> DMSO, <SEP> 40/4 <tb> <SEP> 18 <SEP> hydrin, <SEP> 74 <SEP> droxide, <SEP> 28 <SEP> 150 <tb> <SEP> 22 <SEP> ss-Hydroxy- <SEP> Epichloro- <SEP> Sodium <SEP> hy- <SEP> DMSO, <SEP> 40/4 <tb> <SEP> propionam- <SEP> hydrin, <SEP> 74 <SEP> droxide, <SEP> 28 <SEP> 150 <tb> <SEP> ide, <SEP> 18 <tb> <SEP> 23 <SEP> Urea, <SEP> 9 <SEP> Epichloro- <SEP> Sodium <SEP> hy- <SEP> DMSO, <SEP> 40/4 <tb> <SEP> hydrin, <SEP> 83 <SEP> droxide, <SEP> 28 <SEP> 150 <tb> <SEP> 24 <SEP> Adipamide, <SEP> Epichloro- <SEP> Potassium <SEP> hy- <SEP> DMSO, <SEP> 50/4 <tb> <SEP> 21 <SEP> hydrin, <SEP> 83 <SEP> droxide, <SEP> 39 <SEP> 150 <tb> <SEP> 25 <SEP> Oxamide, <SEP> Epichloro- <SEP> Potassium <SEP> hy- <SEP> DMSO, <SEP> 50/4 <tb> <SEP> 13 <SEP> hydrin, <SEP> 83 <SEP> droxide, <SEP> 39 <SEP> 150 <tb> DMAC: N,N-Dimethylacetamide. NMP: N-Methyl-2-pyrrolidone. Table 6 EMI36.1 Example <SEP> Product <SEP> Yield <SEP> (g) <SEP> Refractive <SEP> Epoxy <SEP> equiv <SEP> (percentage) <SEP> index <SEP> alent <SEP> (g/eq.) <tb> <SEP> (25 C) <SEP> (theoretical <tb> <SEP> value) <tb> <SEP> 12 <SEP> N-N-Dlglycidylphenyl- <SEP> 42(86) <SEP> 1.5309 <SEP> 133(124) <tb> <SEP> acetamide <tb> <SEP> 13 <SEP> N-N-Diglycidyl-p- <SEP> 41(83) <SEP> 1.5459 <SEP> 137(124) <tb> <SEP> tolylamide <tb> <SEP> 14 <SEP> N, <SEP> N, <SEP> N', <SEP> N'-Tetraglycidyl- <SEP> 51(88) <SEP> 1.5469 <SEP> 107(97) <tb> <SEP> isophtalmide <tb> <SEP> 15 <SEP> N, <SEP> N, <SEP> N', <SEP> N'-Tetraglycidyl- <SEP> 44(76) <SEP> 1.5378 <SEP> 113(97) <tb> <SEP> terephtalmide <tb> <SEP> 16 <SEP> N, <SEP> N, <SEP> N', <SEP> N'-Tetraglycidyl- <SEP> 35(61) <SEP> 1.4950 <SEP> 131(97) <tb> <SEP> phtalmide <tb> <SEP> 17 <SEP> N, <SEP> n-Diglycidyl-p- <SEP> 48(78) <SEP> 1.5525 <SEP> 111(102) <tb> <SEP> glycidoxybenzamide <tb> <SEP> 18 <SEP> N, <SEP> N-Diglycidyl-o- <SEP> 40(65) <SEP> 1.5493 <SEP> 132(102) <tb> <SEP> glycidoxybenzamide <tb> <SEP> 19 <SEP> N, <SEP> N, <SEP> N', <SEP> N'-tetraglycidyl- <SEP> 26(52) <SEP> 1.5002 <SEP> 100(85) <tb> <SEP> furamide <tb> Table 6 (Cont'd) EMI37.1 Example <SEP> Product <SEP> Yield <SEP> (g) <SEP> Refractive <SEP> Epoxy <SEP> equiv <SEP> (percentage) <SEP> index <SEP> alent <SEP> (g/eq.) <tb> <SEP> (25 C) <SEP> (theoretical <tb> <SEP> value) <tb> 20 <SEP> N, <SEP> N-Diglycidylmono- <SEP> 9(21) <SEP> 1.4903 <SEP> 145(103) <tb> <SEP> chloroacetamide <tb> 21 <SEP> N, <SEP> N-Diglycidyl-#- <SEP> 39(76) <SEP> 1.4842 <SEP> 117(86) <tb> <SEP> glycidoxypropinamide <tb> 22 <SEP> N, <SEP> N-Diglycidyl-#- <SEP> 43(83) <SEP> 1.4796 <SEP> 91(86) <tb> <SEP> glycidoxypropionamide <tb> 23 <SEP> N, <SEP> N,N', <SEP> N'-Tetraglycidyl- <SEP> 9(20) <SEP> 1.4900 <SEP> 139(71) <tb> <SEP> urea <tb> 24 <SEP> N, <SEP> N, <SEP> N', <SEP> N'-Tetraglycidyl- <SEP> 5(8) <SEP> 1.5040 <SEP> 142(92) <tb> <SEP> adipamide <tb> 25 <SEP> N, <SEP> N, <SEP> N', <SEP> N'-Tetraglycidyl- <SEP> 23(48) <SEP> 1.4863 <SEP> 109(78) <tb> <SEP> oxamide <tb> Example 26 (Preparation of N-methyl-N-glycidylacrylamide) To 150 ml of sulfolane were added 14 g of acrylamide, 0.05 g of phenothiazine, 37 g of epichlorohydrin, and 20 g of sodium hydroxide, followed by bubbling 15 g of methyl chloride thereinto. The resulting mixture was allowed to react at 400C for 3 hours. After completion of the reaction, the reaction mixture was filtered to remove any insoluble matter, and the filtrate was distilled under reduced pressure. A fraction boiling at 57-590C (2 mmHg) was collected to obtain 18 g of N-methyl-N-glycidylacrylamide in a 63% yield. Titration with perchlorate revealed that its epoxy equivalent was 142 g/eq. (theoretical value, 141 g/eq.). Examples 27 and 28 Using the combinations of starting materials, strongly basic substance and solvent shown in Table 7, reaction was carried out under the conditions shown in Table 7. After completion of the reaction, the reaction mixture was worked up in entirely the same manner as in Example 26 to obtain the results shown in Table 8. Table 7 EMI39.1 <SEP> Amide <SEP> Halogen- <SEP> Strongly <SEP> Reaction <SEP> tem Example <SEP> compound <SEP> substitued <SEP> basic <SEP> sub <SEP> Solvent <SEP> perature <SEP> ( C)/ <tb> <SEP> (g) <SEP> compound <SEP> (g) <SEP> stance <SEP> (g) <SEP> (ml) <SEP> time <SEP> (h) <tb> 27 <SEP> Methacryl- <SEP> Methyl <SEP> chlo- <SEP> Potassium <SEP> hy- <SEP> Tetra- <SEP> 40/2 <tb> <SEP> amide, <SEP> 17 <SEP> ridde, <SEP> 15 <SEP> droxyde,28 <SEP> glyme, <tb> <SEP> Epichloro- <SEP> 150 <tb> <SEP> hydrin, <SEP> 37 <tb> 28 <SEP> Acetamide <SEP> Methyl <SEP> chlo- <SEP> Sodium <SEP> hy- <SEP> Sulfo- <SEP> 40/4 <tb> <SEP> 12 <SEP> ride, <SEP> 15 <SEP> droxyde, <SEP> 20 <SEP> lane, <tb> <SEP> Eplchloro- <SEP> 150 <tb> <SEP> hydrin, <SEP> 37 <tb> Table 8 EMI39.2 <SEP> Distillation <SEP> con- <SEP> Epoxy <SEP> equiv Example <SEP> Product <SEP> ditions <SEP> [tempera- <SEP> Yield <SEP> (g) <SEP> alent <SEP> (g/eq.) <tb> <SEP> ture <SEP> ( C)/pressure <SEP> (percentage) <SEP> (theoretical) <tb> <SEP> (mmHg)] <SEP> value) <tb> 27 <SEP> N-Methyl-N-gly- <SEP> 59-61/3 <SEP> 20(64) <SEP> 155(155) <tb> <SEP> cidylmethacryl <tb> 28 <SEP> N-Methyl-n-gly- <SEP> 46-48/3 <SEP> 16(60) <SEP> 129(129) <tb> <SEP> cidylacetamide <tb> Example 29 (Adhesion test) N,N-Diglycidyl-p-glycidoxybenzamide, which had been prepared in Example 17, was subjected to an adhesion test in which steel plates were bonded with the following formulation. o Formulation A mixture of 100 parts of N,N-diglycidyl-pglycidoxybenzamide, 6 parts of dicyandiamide, and 2 parts of aerosil was intimately blended in a three-roll mill. Subsequently, 30 parts of alumina was uniformly dispersed in the blend, which was deaerated under reduced pressure to obtain a formulation. o Preparation of a specimen A 25 mm (width) x 100 mm (length) x 1.6 mm (thickness) steel plate (JIS G3141) was degreased with acetone, and the above formulation was applied to a terminal region of one surface thereof to a length of 12.5 mm. Another similar steel plate was superposed thereon and both plates were fastened with a clip. Then, the formulation was cured at 1800C for 60 minutes to form a specimen. o Testing When measured according to the procedure of JIS K6850, the tensile shear strength of the specimen was found to be 190 kg/cm2. Example 30 (Preparation of N,N-di-2-methylglycidylpropionamide) To 250 ml of DMSO were added 18 g of propionamide, 133 g of B-methylepichlorohydrin, and 30 g of sodium hydroxide. The resulting mixture was allowed to react at 300C for 5 hours. After completion of the reaction, the reaction mixture was filtered to remove any insoluble matter, and then stripped of the starting materials and the solvent. To the residue were added 200 ml of benzene and 100 ml of distilled water. After vigorous stirring, the resulting mixture was separated in a separatory funnel and the aqueous layer was further extracted twice with 100-ml portions of benzene. The combined benzene layers were dried over magnesium sulfate and then distilled under reduced pressure. A fraction boiling at 68-700C (0.04 mmHg) was collected to obtain 35 g of N,N-di-2-methylglycidylpropionamide in a 65% yield. Titration with perchlorate revealed that its epoxy equivalent was 108 g/eq. (theoretical value, 107 g/eq.). Examples 31 to 33 Using the combinations of starting materials, strongly basic substance and solvent shown in Table 9 and the reaction conditions also shown in Table 9, reaction was carried out in entirely the same manner as in Example 30. In Examples 31 and 33, 0.05 g of phenothiazine was added to the reaction mixture. After completion of the reaction, the reaction mixture was worked up in entirely the same manner as in Example 30 to obtain the results shown in Table 10. Example 35 (Preparation of N-allyl-N-2-methylglycidylacrylamide) To 250 ml of DMF were added 18 g of acrylamide, 57 g of allyl chloride, 80 g of B-methylepichlorohydrin, 42 g of potassium hydroxide, and 0.05 g of phenothiazine. The resulting mixture was allowed to react at 300C for 5 hours. After completion of the reaction, the reaction mixture was filtered to remove any insoluble matter, and then stripped of the starting materials and the solvent. To the residue were added 200 ml of benzene and 100 ml of distilled water. After vigorous stirring, the resulting mixture was separated in a separatory funnel and the aqueous layer was further extracted twice with 100-ml portions of benzene. The combined benzene layers were dried over magnesium sulfate and then distilled under reduced pressure. A fraction boiling at 53-55"C (0.9 mmHg) was collected to obtain 24 g of N-allyl-N-2-methylglycidylacrylamide in a 53% yield. Titration with perchlorate revealed that its epoxy equivalent was 182 g/eq. (theoretical value, 181 g/eq.) Examples 37 to 39 Using the combinations of starting materials, strongly basic substance and solvent shown in Table 11 and the reaction conditions also shown in Table 11, reaction was carried out in entirely the same manner as in Example 35. After completion of the reaction, the reaction mixture was worked up in entirely the same manner as in Example 35 to obtain the results shown in Table 12. Example 40 (Preparation of N,N,N',N'-tetra-2-methylglycidyl- isophthalamide) To 250 ml of DMSO were added 21 g of isophthalamide, 133 g of B-methylepichlorohydrin, and 30 g of sodium hydroxide. The resulting mixture was allowed to react at 30"C for 5 hours. After completion of the reaction, the reaction mixture was filtered to remove any insoluble matter, and then stripped of the starting materials and the solvent. To the residue were added 200 ml of benzene and 100 ml of distilled water. After vigorous stirring, the resulting mixture was separated in a separatory funnel and the aqueous layer was further extracted twice with 100-ml portions of benzene. The combined benzene layers were dried over magnesium sulfate. After benzene was distilled off, the remaining solvent and the like were removed by distillation at 1200C and 2 mmHg to obtain 42 g of N,N,N',N'-tetra-2methylglycidylisophthalamide in an 83% yield. Titration with perchlorate revealed that its epoxy equivalent was 121 g/eq. (theoretical value, 111 g/eq.) Moreover, its refractive index at 250C was found to be 1.5311. Examples 41 to 47 Using the combinations of starting materials, strongly basic substance and solvent shown in Table 13 and the reaction conditions also shown in Table 13, reaction was carried out in entirely the same manner as in Example 40. After completion of the reaction, the reaction mixture was worked up in entirely the same manner as in Example 40 to obtain the results shown in Table 14. Example 48 N,N-Di-2-methylglycidyl-p-2-methylglycidoxybenzamide, which had been prepared in Example 43, was subjected to an adhesion in which steel plates were bonded with the following formulation. o Formulation A mixture of 100 parts of N,N-di-2-methylglycidylp-2-methylglycidoxybenzamide, 5 parts of dicyandiamide, and 2 parts of aerosil was intimately blended in a three-roll mill. Subsequently, 30 parts of alumina was uniformly dispersed in the blend, which was deaerated under reduced pressure to obtain a formulation. o Preparation of a specimen A 25 mm (width) x 100 mm (length) x 1.6 mm (thickness) steel plate (JIS G3141) was degreased with acetone, and the above formulation was applied to a terminal region of one surface thereof to a length of 12.5 mm. Another similar steel plate was superposed thereon and both plates were fastened with a clip. Then, the formulation was cured at 1800C for 60 munites to form a specimen. o Testing When measured according to the procedure of JIS K6850, the tensile shear strength of the specimen was 2 found to be 180 kg/cm Table 9 EMI46.1 <SEP> Amide <SEP> Halogen <SEP> Strongly <SEP> Reaction <SEP> tem Example <SEP> compound <SEP> substitued <SEP> basic <SEP> sub- <SEP> Solvent <SEP> perature( C)/ <tb> <SEP> (g) <SEP> compound <SEP> (g) <SEP> stance <SEP> (g) <SEP> (ml) <SEP> time <SEP> (h) <tb> 31 <SEP> Acrylamide, <SEP> #-Methylepichlo- <SEP> Sodium <SEP> hy- <SEP> DMF, <SEP> 30/5 <tb> <SEP> 18 <SEP> rohydrin, <SEP> 133 <SEP> droxyde, <SEP> 30 <SEP> 250 <tb> 32 <SEP> Methacryl- <SEP> #-Methyleplchlo- <SEP> Sodium <SEP> hy- <SEP> DMF, <SEP> 30/5 <tb> <SEP> amide, <SEP> 22 <SEP> rohydrin, <SEP> 133 <SEP> droxyde, <SEP> 30 <SEP> 250 <tb> 33 <SEP> Acetamide, <SEP> #-Methylepichlo- <SEP> Sodium <SEP> hy- <SEP> DMSO, <SEP> 30/5 <tb> <SEP> 15 <SEP> rohydrin, <SEP> 133 <SEP> droxyde, <SEP> 30 <SEP> 250 <tb> Table 10 EMI46.2 <SEP> Distillation <SEP> con- <SEP> Epoxy <SEP> equiv Example <SEP> Product <SEP> ditions <SEP> [tempera- <SEP> Yield <SEP> (g) <SEP> alent <SEP> (g/eq.) <tb> <SEP> ture <SEP> ( C)/ <SEP> pressure <SEP> (percentage) <SEP> (theoretical) <tb> <SEP> (mmHg)] <SEP> value) <tb> 31 <SEP> N, <SEP> N-Di-2-methylglyci- <SEP> 95/0.3 <SEP> 39(74) <SEP> 107(106) <tb> <SEP> dylacrylamide <tb> 32 <SEP> N, <SEP> N-Di-2-methylglyci- <SEP> 87/0.3 <SEP> 41(73) <SEP> 114(113) <tb> <SEP> dylmethacrylamide <tb> 33 <SEP> N, <SEP> N-Di-2-methylglyci- <SEP> 70/0.3 <SEP> 30(60) <SEP> 101(100) <tb> <SEP> dylacetamide <tb> Table 11 EMI47.1 <SEP> Amide <SEP> Halogen <SEP> Strongly <SEP> Reaction <SEP> tem Example <SEP> compound <SEP> substituted <SEP> basic <SEP> sub- <SEP> Solvent <SEP> perature <SEP> ( C)/ <tb> <SEP> (g) <SEP> compound <SEP> (g) <SEP> stance <SEP> (g) <SEP> (ml) <SEP> time <SEP> (h) <tb> 35 <SEP> Methacryl- <SEP> Allyl <SEP> chloride, <SEP> Potassium <SEP> DMF, <SEP> 30/5 <tb> <SEP> amide, <SEP> 22 <SEP> 57 <SEP> hydroxyde, <SEP> 250 <tb> <SEP> #-Methylepichlo- <SEP> 42 <tb> <SEP> rohydrin, <SEP> 8 <tb> 36 <SEP> Acetamide, <SEP> Allyl <SEP> chloride, <SEP> Potassium <SEP> DMF, <SEP> 30/5 <tb> <SEP> 15 <SEP> 57 <SEP> hydroxyde, <SEP> 250 <tb> <SEP> #-Methylepichlo- <SEP> 42 <tb> <SEP> rohydrln, <SEP> 80 <tb> 37 <SEP> Acrylamide, <SEP> 1-Bromobutane, <SEP> Potassium <SEP> DMSO, <SEP> 30/5 <tb> <SEP> 18 <SEP> 48 <SEP> hydroxyde, <SEP> 250 <tb> <SEP> #-Methylepichlo- <SEP> 42 <tb> <SEP> rohydrin,80 <tb> Table 12 EMI48.1 <SEP> Distillation <SEP> con- <SEP> Epoxy <SEP> equiv Example <SEP> product <SEP> dition <SEP> [tempera- <SEP> Yield <SEP> (g) <SEP> alent <SEP> 8g/eq,) <tb> <SEP> ture <SEP> ( C)/ <SEP> pressure <SEP> (percentage) <SEP> (theoretical <tb> <SEP> (mmHg)] <SEP> value) <tb> 35 <SEP> N-Allyl-n-2-methyl- <SEP> 62/0.3 <SEP> 25(51) <SEP> 196(195) <tb> <SEP> glycidylmethacyl <SEP> amide <tb> 36 <SEP> N-Allyl-N-2-methyl- <SEP> 40/0.4 <SEP> 17(41) <SEP> 170(169) <tb> <SEP> glycidylacetamide <tb> 37 <SEP> N-Butyl-N-2-methyl- <SEP> 34/0.3 <SEP> 25(51) <SEP> 199(197) <tb> <SEP> glycidylacrylamide <tb> Table 13 EMI49.1 <SEP> Amide <SEP> Halogen <SEP> Strongly <SEP> Reaction <SEP> tem Example <SEP> compound <SEP> substituted <SEP> basic <SEP> sub <SEP> Solvent <SEP> perature <SEP> ( C)/ <tb> <SEP> (g) <SEP> compound <SEP> (g) <SEP> stance <SEP> (g) <SEP> (ml) <SEP> time(h) <tb> 39 <SEP> Terephthal- <SEP> #-Methylepichlo- <SEP> Sodium <SEP> hy- <SEP> DMSO, <SEP> 50/5 <tb> <SEP> amide, <SEP> 21 <SEP> rohydrin,133 <SEP> droxyde, <SEP> 30 <SEP> 250 <tb> 40 <SEP> Benzamide, <SEP> #-Methylepichlo- <SEP> Sodium <SEP> hy- <SEP> DMSO, <SEP> 30/5 <tb> <SEP> 30 <SEP> rohydrin, <SEP> 133 <SEP> droxyde, <SEP> 30 <SEP> 250 <tb> 41 <SEP> p-Hydroxy- <SEP> #-Methylepichlo- <SEP> Sodium <SEP> hy- <SEP> DMSO, <SEP> 20/5 <tb> <SEP> benzamide, <SEP> rohydrin, <SEP> 133 <SEP> droxyde, <SEP> 30 <SEP> 250 <tb> <SEP> 26 <tb> 42 <SEP> Salicyl- <SEP> #-Methylepichlo- <SEP> Sodium <SEP> hy- <SEP> DMSO, <SEP> 20/5 <tb> <SEP> amide, <SEP> 26 <SEP> rohydrin, <SEP> 133 <SEP> droxyde, <SEP> 30 <SEP> 250 <tb> 43 <SEP> Phenylacet- <SEP> #-Methylepichlo- <SEP> Sodium <SEP> hy- <SEP> DMSO, <SEP> 30/5 <tb> <SEP> amide, <SEP> 34 <SEP> rohydrin, <SEP> 133 <SEP> droxyde, <SEP> 30 <SEP> 250 <tb> 44 <SEP> Oxamide, <SEP> #-Methylepichlo- <SEP> Sodium <SEP> hy- <SEP> DMSO, <SEP> 30/5 <tb> <SEP> 11 <SEP> rohydrin, <SEP> 133 <SEP> droxyde, <SEP> 30 <SEP> 250 <tb> 45 <SEP> Lactamide, <SEP> #-Methylepichlo- <SEP> Sodium <SEP> hy- <SEP> DMSO, <SEP> 20/5 <tb> <SEP> 17 <SEP> rohydrin, <SEP> 133 <SEP> droxyde, <SEP> 30 <SEP> 250 <tb> Tablew 14 EMI50.1 <SEP> Epoxy <SEP> equiv <SEP> Refractive <SEP> alent <SEP> (g/eq.) <tb> Example <SEP> Product <SEP> Yield <SEP> (g) <SEP> index <SEP> (theoretical) <tb> <SEP> (percentage) <SEP> (25 C) <SEP> value) <tb> 39 <SEP> N, <SEP> N, <SEP> N', <SEP> N'-Tetra-2-methyl- <SEP> 34(61) <SEP> 1.5262 <SEP> 140(111) <tb> <SEP> glycidylterephtalamide <tb> 40 <SEP> N, <SEP> N-Di-2-methylglycidyl- <SEP> 55(84) <SEP> 1.5265 <SEP> 155(131) <tb> <SEP> benzamide <tb> 41 <SEP> N, <SEP> N-Di-2-methylglycidyl-p-2- <SEP> 49(74) <SEP> 1.5345 <SEP> 150(116) <tb> <SEP> methylglycidoxybenzamide <tb> 42 <SEP> N, <SEP> N-Di-2-methylglycidyl-o-2- <SEP> 31(47) <SEP> 1.5498 <SEP> 208(116) <tb> <SEP> methylglycidoxybenzimade <tb> 43 <SEP> N, <SEP> N-Di-2-methylglycidyl- <SEP> 47(68) <SEP> 1.5205 <SEP> 183(137) <tb> <SEP> phenylacetamide <tb> 44 <SEP> N, <SEP> N, <SEP> N', <SEP> N'-Tetra-2-methyl- <SEP> 21(45) <SEP> 1.4869 <SEP> 106(92) <tb> <SEP> glycidyloxamide <tb> 45 <SEP> N, <SEP> N-Di-2-methylglycidyl-#-2- <SEP> 33(58) <SEP> 1.4705 <SEP> 133(100) <tb> <SEP> methylglycidoxyproplonamide <tb>

Claims: CLAIMS 1. An N-glycidyl-substituted amide compound having the general formula EMI51.1 where R1 is an aliphatic hydrocarbon radical, an aromatic hydrocarbon radical, or an alicyclic hydrocarbon radical; X is a hydrogen atom, a glycidoxy group, a 2-methylglycidoxy group, an N,N-diglycidylamino group, or an N,N-di-2-methylglycidylamino group; p is an integer of O or 1; q is an integer of 1 to 4; R2 is a hydrogen atom or a methyl group, and when R2 is a hydrogen atom, X is a hydrogen atom, a glycidoxy group, or an N,N-diglycidylamino group, while when R2 is a methyl group, X is a hydrogen atom, a 2-methylglycidoxy group, or an N,N-di-2-methylglycidylamino group; R3 is an alkyl group, an alkenyl group, or an aryl group; r is an integer of 1 or 2; and s is an integer of 1 to 4; provided that when X is a hydrogen atom, p is O or 1 and q is O or 1, in the case that s is 1, r is 1 or 2, and in the case that s is from 2 to 4, r is 2; when X is a glycidoxy group or a 2-methylglycidoxy group, p is 1 and r is 2; and when X is an N,N-diglycidylamino group or an N,N-di-2methylglycidylamino group, p is O or 1, q is 1 or 2, s is 1 or 2, and r is 2. 2. A compound as claimed in claim 1 which is N,N-diglycidylpropionamide, N,N-diglycidylacrylamide, N,N-diglycidylmethacrylamide, N,N-diglycidylcrotonamide, N,N-diglycidylbenzamide, N,N-diglycidylphenylacetamide, N,N-diglycidyl-p-tolylamide, N-methyl-N-glycidylacetamide, N-methyl-N-glycidylacrylamide, N-methyl-N-glycidylmethacrylamide, N-n-butyl-N-glycidylacrylamide, N-allyl-Nglycidylacetamide, N-allyl-N-glycidylacrylamide, Nbenzyl-N-glycidylacrylamide, N-allyl-N-glycidylmethacrylamide, N-methyl-N-glycidylbenzamide, or N,N-diglycidylmonochloroacetamide. 3. A compound as claimed in claim 1 which is N,N-di-2-methylglycidylacetamide, N,N-di-2-methylglycidylpropionamide, N,N-di-2-methylglycidylacrylamide. N.N-di2-methylglycidylmethacrylamide, N,N-di-2-methylglycidylbenzamide, N,N-di-2-methylglyidylphenylacetamide, N-butyl N-2-methylglycidylacrylamide, N-allyl-N-2-methylglycidyl acetamide, N-allyl-N-2-methylglycidylacrylamide, or N-allyl -N-2-methylglycidylmethacrylamide. 4. A compound as claimed in claim 1 which is N,N,N',N'-tetraglycidyloxamide, N,N,N',N'-tetraglycidyladipamide, N,N,N',N'-tetraglycidylfumaramide, N,N,N' ,N'- tetraglycidylisophthalamide, N,N,N' ,N'-tetraglycidyl- terephthalamide, N,N,N',N'-tetraglycidylphthalamide, or N,N,N',N'-tetraglycidylurea. 5. A compound as claimed in claim 1 which is N,N,N',N'-tetra-2-methylglycidyloxamide, N,N,N',N'-tetra2-methylglycidylisophthalamide, or N,N,N',N'-tetra-2methylglycidylterephthalamide. 6. A compound as claimed in claim 1 which is N,N-diglycidyl-a-glycidoxypropionamide, N,N-diglycidyl-B- glycidoxypropionamide, N,N-diglycidyl-p-glycidoxybenzamide, or N,N-diglycidyl-o-glycidoxybenzamide. 7. A compound as claimed in claim 1 which is N,N-di-2-methylglycidyl-a-2-methylglycidoxypropionamide, N,N-di-2-methylglycidyl-p-2-methylglycidoxybenzamide, or N,N-di- 2-methylglycidyl-o-2-methylglycidoxybenzamide. Amended Claim filed to the International Bureau 1. An N-glycidyl-substituted amide compound having the general formula EMI54.1 where R1 is an aliphatic hydrocarbon radical, an aromatic hydrocarbon radical, or an alicyclic hydrocarbon radical; X is a hydrogen atom, a glycidoxy group, a 2-methylglycidoxy group, an N,N-diglycidylamino group, or an N,N-di-2-methylglycidylamino group; p is an integer of 0 or 1; q is an integer of 0 to 4; R2 is a hydrogen atom or a methyl group, and when R2 is a hydrogen atom, X is a hydrogen atom, a glycidoxy group, or an N,N-diglycidylamino group, while when R2 is a methyl group, X is a hydrogen atom, a 2-methylglycidoxy group, or an N,N-di-2-methylglycidylamino group; R3 is an alkyl group, an alkenyl group, or an aryl group; r is an integer of 1 or 2; and s is an integer of 1 to 4; provided that when X is a hydrogen atom and s is 1, p is 0 or 1, q is 0 or 1 and r is 1 or 2; when X is a hydrogen atom and S is from 2 to 4, p is 0 or 1, q is 0 or 1 and r is 2; when X is a glycidoxy group or a 2-methylglycidoxy group, p is 1 and r is 2; and when X is an N,N-diglycidylamino group or an N,N-di-2methylglycidylamino group, p is 0 or 1, q is 1 or 2, s is 1 or 2, and r is 2.

Inventors: ITOH, HIROSHI, KAMIO, HIDEO, NITTA, ATSUHIKO, TANAKA, TOMIO, TSUBOI, KENJI
Applicants: MITSUI TOATSU CHEMICALS, INCORPORATED
Application year: 1982
Main classification: C07D303
IPC codes: C07D303